Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee B Reichman

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Annual Review of Public Health|March 23, 2002
TuberculosisParvathi Tiruviluamala, Lee B Reichman
American Journal of Respiratory and Critical Care Medicine|June 28, 2005
And the beat goes onLee B Reichman, Bonita T Mangura
Pediatrics|June 1, 2019
The Case for Retiring the Tuberculin Skin TestAndrea T Cruz, Lee B Reichman
Microbiology Spectrum|February 11, 2017
Diagnosis of Latent Tuberculosis InfectionAlfred A Lardizabal, Lee B Reichman
The European Respiratory Journal|October 2, 2012
Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in EuropeFrancesco Blasi, Lee B Reichman, Giovanni Battista Migliori
The Lancet. Infectious Diseases|July 26, 2017
Whither "latent"?Lee B Reichman, Anita Khilall, Alfred A Lardizabal
American Journal of Respiratory and Critical Care Medicine|August 7, 2004
Considering the role of four months of rifampin in the treatment of latent tuberculosis infectionLee B Reichman, Alfred Lardizabal, Christopher H Hayden
Current Opinion in Infectious Diseases|April 20, 2002
Update: prevention and treatment of tuberculosisAkingboju Gbayisomore, Alfred A. Lardizabal, Lee B. Reichman
Emerging Infectious Diseases|November 20, 2020
Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and ControlPhilip C Hopewell, Lee B Reichman, Kenneth G Castro
Chest|December 15, 2006
Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampinAlfred Lardizabal, Marian Passannante, Faysal Kojakali, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Annual Review of Public Health|March 23, 2002
TuberculosisParvathi Tiruviluamala, Lee B Reichman
American Journal of Respiratory and Critical Care Medicine|June 28, 2005
And the beat goes onLee B Reichman, Bonita T Mangura
Pediatrics|June 1, 2019
The Case for Retiring the Tuberculin Skin TestAndrea T Cruz, Lee B Reichman
Microbiology Spectrum|February 11, 2017
Diagnosis of Latent Tuberculosis InfectionAlfred A Lardizabal, Lee B Reichman
The European Respiratory Journal|October 2, 2012
Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in EuropeFrancesco Blasi, Lee B Reichman, Giovanni Battista Migliori
The Lancet. Infectious Diseases|July 26, 2017
Whither "latent"?Lee B Reichman, Anita Khilall, Alfred A Lardizabal
American Journal of Respiratory and Critical Care Medicine|August 7, 2004
Considering the role of four months of rifampin in the treatment of latent tuberculosis infectionLee B Reichman, Alfred Lardizabal, Christopher H Hayden
Current Opinion in Infectious Diseases|April 20, 2002
Update: prevention and treatment of tuberculosisAkingboju Gbayisomore, Alfred A. Lardizabal, Lee B. Reichman
Emerging Infectious Diseases|November 20, 2020
Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and ControlPhilip C Hopewell, Lee B Reichman, Kenneth G Castro
Chest|December 15, 2006
Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampinAlfred Lardizabal, Marian Passannante, Faysal Kojakali, et al.
Pageof 3